CVRx receives FDA approval for expanded labeling of
U.S. annual market opportunity increases based on real world adoption and strength of long-term BeAT-HF data...
Source: globenewswire.com
📰 Clinical Summary News
Clinical Summary News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Clinical Summary. Real-time updates on events, politics, business and more.
CVRx, Inc. Receives FDA Approval for Expanded Labing of Barostim
CVRx, Inc. announced that the U.S. Food and Drug Administration has approved revised Instructions For Use for Barostim incorporating key long-term clinical data from the BeAT-HF randomized clinical...
Cvrx Inc Drug Administration Instructions For Use Baroreflex Activation Therapy Clinical Summary Pre Market Phase
Source: marketscreener.com
U.S. Food and Drug Administration Approves Addition of Positive Data from Phase 3 VALOR-HCM Study to CAMZYOS (mavacamten) Label
16.06.2023 - Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) to add positive data from the Phase 3 VALOR-HCM study to the U.S. Prescribing Information for ...
Anjalit Owens Bristol Myers Squibb York Heart Association Bristol Myers Squibb Company Exchange Commission Journal Of The American College Cardiology
Source: wallstreet-online.de
Clinical Overview and Clinical Summary Training Course: Creating Effective Marketing Authorisation Applications - Regulatory Guidelines and Requirements of Module 2 (February 8-9, 2023)
/PRNewswire/ -- The "Clinical Overview and Clinical Summary: Creating Effective Marketing Authorisation Application Training Course" conference has been added...
United States John Price Laura Wood Alexion Pharmaceuticals Office Hours Call Medicines Control Agency
Source: prnewswire.com
April | 2011 | HIT Consultant
10 posts published by hitconsultant during April 2011
United States Peter Neupert Mark Roman Mary Anne Kelly Falls Church Health Information Technology For Economic
Source: hitconsultant.net
Guidance for licensing electronic cigarettes and other inhaled nicotine-containing products as medicines
Guidance on how to licence electronic cigarettes and other inhaled nicotine-containing products (NCPs) as medicines in the UK.
Source: gov.uk